We are live on ! Find out more
TENX icon

Tenax Therapeutics
TENX

11 hedge funds and large institutions have $1.31M invested in Tenax Therapeutics in 2017 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

0% less ownership

Funds ownership: 0% → 0% (-0%)

42% less funds holding

Funds holding: 19 → 11 (-8)

55% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 11

67% less call options, than puts

Call options by funds: $1K | Put options by funds: $3K

94% less capital invested

Capital invested by funds: $20.3M → $1.31M (-$19M)

Holders
11
Holders Change
-8
Holders Change %
-42.11%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
2
Reduced
1
Closed
11
Calls
$1K
Puts
$3K
Net Calls
-$2K
Net Calls Change
-$2.37M

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$291K
2
Millennium Management
Millennium Management
New York
+$182K
3
BlackRock
BlackRock
New York
+$72.7K
4
Citadel Advisors
Citadel Advisors
Florida
+$36.3K
5
DADC
D.A. Davidson & Co
Montana
+$36.3K

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$4.66M
2
BC
Broadfin Capital
New York
-$3.84M
3
GPP
Great Point Partners
Connecticut
-$2.16M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
-$975K
5
BBA
Baker Bros. Advisors
New York
-$819K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$658K +$291K +8 +28%
SM
2
Sabby Management
Florida
$300K -$400K -11 -23%
Millennium Management
3
Millennium Management
New York
$91K +$182K +5 New
Bank of New York Mellon
4
Bank of New York Mellon
New York
$71K – – –
Geode Capital Management
5
Geode Capital Management
Massachusetts
$51K – – –
BlackRock
6
BlackRock
New York
$39K +$72.7K +2 New
Northern Trust
7
Northern Trust
Illinois
$29K +$36.3K +1 +100%
Citadel Advisors
8
Citadel Advisors
Florida
$19K +$36.3K +1 New
Verition Fund Management
9
Verition Fund Management
Connecticut
$18K – – –
DADC
10
D.A. Davidson & Co
Montana
$11K +$36.3K +1 New
Group One Trading
11
Group One Trading
Illinois
$10K +$36.3K +1 New
WA
12
WFG Advisors
Texas
$8K – – –
CCMINC
13
Cardinal Capital Management Inc (North Carolina)
North Carolina
$6K – – –
Creative Planning
14
Creative Planning
Kansas
$1K -$36.3K -1 Closed
AG
15
Advisor Group
Arizona
$1K – – –
Morgan Stanley
16
Morgan Stanley
New York
$1K – – –
FDCDDQ
17
Federation des caisses Desjardins du Quebec
Quebec, Canada
$676 – – –
RCM
18
RA Capital Management
Massachusetts
– -$4.66M -75 Closed
BC
19
Broadfin Capital
New York
– -$3.84M -62 Closed
GPP
20
Great Point Partners
Connecticut
– -$2.16M -35 Closed
Point72 Asset Management
21
Point72 Asset Management
Connecticut
– -$975K -16 Closed
BBA
22
Baker Bros. Advisors
New York
– -$819K -13 Closed
Deutsche Bank
23
Deutsche Bank
Germany
– -$145K -4 Closed
CA
24
Commerzbank Aktiengesellschaft
Germany
– -$195K -3 Closed
BCM
25
Bourgeon Capital Management
Connecticut
– -$137K -2 Closed
1
2

TENX Hedge Fund Activity: Q1 2017 in Review

11 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q1 2017, worth a combined $1.31M — down 94% from $20.3M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of TENX and 5 opened new positions — a net loss of 6 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was Vanguard Group, adding an estimated $291K. The largest seller was RA Capital Management, exiting entirely with an estimated $4.66M sold.

  • 11 institutional investors held Tenax Therapeutics (TENX) as of Q1 2017, down from 19 in Q4 2016.
  • Funds reported $1.31M of Tenax Therapeutics stock for Q1 2017, down 94% quarter-over-quarter.
  • 5 funds opened new Tenax Therapeutics positions in Q1 2017 and 11 closed out, a net change of -6 holders.
  • The largest Tenax Therapeutics buyer in Q1 2017 was Vanguard Group, an estimated $291K added.
  • The largest Tenax Therapeutics seller in Q1 2017 was RA Capital Management, an estimated $4.66M sold.

Based on aggregated 13F filings for Q1 2017.